Bulgaria is an upper-middle-income country in Eastern Europe and a member of the European Union. The country’s HIV burden is low. Tuberculosis presents a greater health risk in Bulgaria, with case numbers more than three times the European Union average. Multidrug-resistant TB is a major health threat in the country, and Global Fund investments focus mainly on early diagnosis and care for people with multidrug-resistant TB.

Investments to Date

Component Signed Committed Disbursed

Disbursements by Component


For documents pertaining to a specific grant, please select a grant from the list.